Jump Trading’s Aegerion Pharmaceuticals AEGR Stock Holding History

Jump Trading’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-1,000	Closed	-$33K	–	1307
2014 Q3	$33K	Buy	+1,000	New	+$31K	﹤0.01%	949

Other funds holding AEGR

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jump Trading's AEGR Position: Q4 2014 in Review

Jump Trading sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2014, closing a stake of 272 shares — an estimated $9K sold.

Jump Trading first reported a position in AEGR in Q3 2014 and held it in 1 quarter. The position peaked at $9K in Q3 2014. 95 funds tracked by Wall St. Rank hold AEGR as of Q4 2014.

Jump Trading reported no remaining Aegerion Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
Jump Trading sold 272 Aegerion Pharmaceuticals shares in Q4 2014, an estimated $9K.
Jump Trading first reported a position in Aegerion Pharmaceuticals in Q3 2014 and held it in 1 quarter.
Jump Trading's Aegerion Pharmaceuticals position peaked at $9K in Q3 2014.
95 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2014.

Based on Jump Trading's 13F filing for Q4 2014, filed 17 Feb 2015.